GDNSF: AI 评分 64/100 — AI 分析 (4月 2026)

Goodness Growth Holdings, Inc. is a physician-led cannabis company operating in the United States. They cultivate cannabis, manufacture extracts, and sell products through their Green Goods dispensaries and third-party retailers.

Key Facts: AI Score: 64/100 Sector: Healthcare

公司概况

概要：

Goodness Growth Holdings, Inc. cultivates and distributes cannabis products through its Green Goods dispensaries and wholesale channels. With a focus on environmentally friendly cultivation and pharmaceutical-grade extracts, the company operates in a rapidly evolving US cannabis market, facing both growth opportunities and regulatory challenges.

GDNSF是做什么的？

Goodness Growth Holdings, Inc., formerly known as Vireo Health International Inc., is a physician-led cannabis company established to cultivate, manufacture, and distribute cannabis products in the United States. Founded with a commitment to environmentally sustainable practices, the company operates greenhouses for cannabis cultivation and produces pharmaceutical-grade cannabis extracts. Goodness Growth sells its products through its network of Green Goods retail dispensaries and via wholesale agreements with third-party dispensaries. As of March 11, 2022, the company managed 18 dispensaries across Maryland, Minnesota, New Mexico, and New York. Additionally, the company supplies wholesale cannabis products to third-party companies in Arizona, Maryland, Minnesota, and New York. The company changed its name to Goodness Growth Holdings, Inc. in June 2021, and is headquartered in Minneapolis, Minnesota. The company aims to provide high-quality cannabis products while maintaining environmentally conscious and physician-led operational standards.

GDNSF的投资论点是什么？

Goodness Growth Holdings, Inc. presents a speculative investment opportunity within the evolving US cannabis market. The company's focus on physician-led operations and environmentally friendly cultivation could appeal to health-conscious consumers and environmentally focused investors. However, the company's negative P/E ratio of -11.69 and a profit margin of -19.4% indicate financial challenges. Growth catalysts include expansion into new states and increased wholesale distribution. Key risks include regulatory uncertainty, competition from larger cannabis companies, and the need to achieve profitability. The company's beta of 1.42 suggests higher volatility compared to the broader market.

GDNSF在哪个行业运营？

Goodness Growth Holdings operates within the rapidly expanding US cannabis market, which is characterized by evolving regulations and increasing consumer acceptance. The industry is highly competitive, with companies like BIOGF (BioHarvest Sciences Inc.), BSTG (BioStar Group, Inc.), EEOIF (Empower Clinics Inc.), EOFBY (EnWave Corporation), and HRPMF (Heritage Cannabis Holdings Corp) vying for market share. The trend towards legalization in more states presents significant growth opportunities, but also regulatory hurdles and compliance costs. Companies that can establish strong brands and efficient operations are best positioned to succeed.

Drug Manufacturers - Specialty & Generic

Healthcare

GDNSF有哪些增长机遇？

Expansion into New States: Legalization of cannabis in additional states presents a significant growth opportunity for Goodness Growth. Entering new markets would allow the company to increase its revenue base and expand its brand presence. The timeline for this growth is dependent on the pace of legalization efforts in various states, but represents a substantial long-term opportunity.
Increased Wholesale Distribution: Expanding its wholesale distribution network to third-party dispensaries can significantly increase Goodness Growth's revenue. By partnering with more dispensaries, the company can reach a wider customer base without the capital expenditures associated with opening new retail locations. This strategy can be implemented relatively quickly, providing near-term revenue growth.
Development of New Cannabis Products: Investing in research and development to create new and innovative cannabis products can drive growth. This includes developing new strains, formulations, and delivery methods to meet evolving consumer preferences. The timeline for this growth depends on the R&D process, but successful product launches can create a competitive advantage.
Focus on Medical Cannabis Market: Goodness Growth's physician-led approach positions it well to capitalize on the medical cannabis market. By focusing on developing cannabis-based therapies for specific medical conditions, the company can attract patients seeking alternative treatments. This market segment is expected to grow as more research supports the therapeutic benefits of cannabis.
Strategic Partnerships and Acquisitions: Forming strategic partnerships with other companies in the cannabis industry or acquiring smaller players can accelerate growth. Partnerships can provide access to new markets, technologies, or distribution channels. Acquisitions can consolidate market share and create synergies. These opportunities can arise at any time, depending on market conditions and company strategy.

Operates 18 dispensaries across Maryland, Minnesota, New Mexico, and New York as of March 11, 2022.
Gross Margin of 43.8% indicates potential for profitability if operating expenses are managed effectively.
Market Cap of $0.06B reflects its small size and potential for high growth or significant risk.
Cultivates cannabis in environmentally friendly greenhouses, appealing to environmentally conscious consumers.
Sells products through both its own Green Goods dispensaries and third-party wholesale channels, diversifying revenue streams.

GDNSF提供哪些产品和服务？

Cultivates cannabis in environmentally friendly greenhouses.
Manufactures pharmaceutical-grade cannabis extracts.
Operates a network of Green Goods retail dispensaries.
Sells cannabis products through third-party dispensaries.
Develops and markets cannabis-based therapies.
Engages in wholesale distribution of cannabis products.

GDNSF如何赚钱？

Cultivation and processing of cannabis.
Retail sales through company-owned dispensaries.
Wholesale distribution to third-party retailers.
Development and sale of cannabis extracts and derivative products.

Medical cannabis patients seeking alternative therapies.
Adult-use cannabis consumers in legalized states.
Third-party dispensaries purchasing wholesale products.
Healthcare providers recommending cannabis treatments.

Physician-led approach provides credibility in the medical cannabis market.
Environmentally friendly cultivation practices appeal to eco-conscious consumers.
Established network of Green Goods dispensaries provides a direct sales channel.
Proprietary formulations and extraction processes create product differentiation.

什么因素可能推动GDNSF股价上涨？

Upcoming: Potential legalization of cannabis in additional states, expanding market opportunities.
Ongoing: Expansion of the Green Goods dispensary network.
Ongoing: Development and launch of new cannabis products and formulations.
Ongoing: Increasing wholesale distribution agreements with third-party dispensaries.

GDNSF的主要风险是什么？

Potential: Regulatory changes and uncertainty in the cannabis industry.
Ongoing: Competition from larger and more established cannabis companies.
Ongoing: Fluctuations in cannabis prices and market demand.
Potential: Difficulty in obtaining financing and capital for expansion.
Ongoing: Negative profit margin and the need to achieve profitability.

GDNSF的核心优势是什么？

Physician-led approach
Environmentally friendly cultivation practices
Established retail dispensary network
Wholesale distribution channels

GDNSF的劣势是什么？

Negative profit margin
Limited geographic presence
Small market capitalization
Reliance on evolving regulatory landscape

GDNSF有哪些机遇？

Expansion into new states
Increased wholesale distribution
Development of new cannabis products
Focus on medical cannabis market

GDNSF面临哪些威胁？

Regulatory uncertainty
Competition from larger cannabis companies
Fluctuations in cannabis prices
Changes in consumer preferences

GDNSF的竞争对手是谁？

BioHarvest Sciences Inc. — Focuses on nutraceutical and functional food applications of cannabis. — (BIOGF)
BioStar Group, Inc. — Operates in the biotechnology and regenerative medicine space, with some cannabis-related activities. — (BSTG)
Empower Clinics Inc. — Operates healthcare clinics offering cannabis-based treatments. — (EEOIF)
EnWave Corporation — Provides dehydration technology for cannabis processing. — (EOFBY)
Heritage Cannabis Holdings Corp — Focuses on the production and distribution of cannabis products. — (HRPMF)

Key Metrics

MoonshotScore: 64/100

Company Profile

CEO: Joshua Nathaniel Rosen
Headquarters: Minneapolis, US
Employees: 385
Founded: 2019

AI Insight

AI analysis pending for GDNSF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Goodness Growth Holdings, Inc. do?

Goodness Growth Holdings, Inc. is a physician-led cannabis company that cultivates, manufactures, and distributes cannabis products in the United States. The company operates environmentally friendly greenhouses for cannabis cultivation and produces pharmaceutical-grade extracts. It sells its products through its Green Goods retail dispensaries and via wholesale agreements with third-party dispensaries. The company focuses on providing high-quality cannabis products while adhering to environmentally conscious and physician-led operational standards, serving both medical and adult-use markets.

What do analysts say about GDNSF stock?

AI analysis is currently pending for GDNSF, so there is no available analyst consensus. Investors should conduct their own due diligence and consider the company's financial performance, growth prospects, and the risks associated with investing in OTC stocks and the cannabis industry. Key valuation metrics to consider include the company's market capitalization, revenue growth, and profitability. The evolving regulatory landscape and competitive dynamics of the cannabis market should also be taken into account.

What are the main risks for GDNSF?

Goodness Growth Holdings, Inc. faces several risks, including regulatory uncertainty in the cannabis industry, competition from larger and more established companies, and fluctuations in cannabis prices and market demand. The company's negative profit margin and the need to achieve profitability also pose significant challenges. As an OTC stock, GDNSF is subject to increased price volatility and liquidity risk. Investors should carefully consider these risks before investing.